|Articles|November 8, 2004

IDSA warns: New antibiotics needed ASAP

Once referred to as "miracle drugs" for their ability to eradicate infection and save countless lives, antibiotics are losing their battle against resistant organisms, and no fresh supply of novel drugs exists. Unless antibiotic research and development is reinvigorated soon, a public health crisis is imminent.

Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.

Latest CME

Online Article

Payment for Pharmacist Services: 2025 Update

1.0 Credit / General Pharmacy, Health Equity, Diversity & Inclusion, Law

IDSA warns: New antibiotics needed ASAP

Related Content

FDA Approves Fitusiran as Prophylaxis of Bleeding Episodes Due to Hemophilia A or B

Q&A: What Role Will Pharmacists Play in Precision Medicine?

Pharmacists Can Act as Navigators for Patients Using Digital Health Tools

Q&A: Challenges Health Systems May Face When Integrating Biosimilars

Pharmacists Will Play Key Role in Integration of Precision Medicine

Latest CME

Payment for Pharmacist Services: 2025 Update

From Treatment to Prevention: Navigating the Expanding Hereditary Angioedema Treatment Landscape

The Oncology Pharmacist's Role in Managing Small Molecule Inhibitor Use in Chronic Lymphocytic Leukemia to Enhance Patient-Centered Care

Redefining Complement-Mediated Kidney Disease: The Latest in Diagnosis and Treatment

Advancing Pharmacist Expertise in R/R FL: Navigating Novel Therapies and Optimizing Patient Outcomes

Innovations in Hidradenitis Suppurativa Treatment: Navigating the Evolving Landscape

Paroxysmal Nocturnal Hemoglobinuria: Managed Care Strategies to Mitigate Burden and Enhance Outcomes

Optimizing Outcomes in Myasthenia Gravis: Therapeutic Advances and Value-Based Care Models

Navigating Novel Therapies in Steroid-Refractory cGVHD: Practical Strategies for Community-Based Oncology Pharmacists

Reducing Transfusion Burden in Myeloid Disorders: Novel Therapeutic Strategies and Pharmacist Interventions

Panel Discussion: Integrating Novel Combinations and Earlier Line Use in Diffuse Large B-Cell Lymphoma

Optimizing Patient Outcomes in R/R DLBCL: Bridging Knowledge Gaps for Oncology Pharmacists in the Era of Novel Immunotherapies

Clinical Panel Debate: CAR T-Cell Therapy vs Bispecific Antibodies

From Molecules to Medicine: Pharmacologic Principles of Innovative Non-Hodgkin Lymphoma Therapies

The Pharmacist's Role in Palliative and End of Life Symptom Management (Pharmacy Technician Credit)

The Pharmacist's Role in Palliative and End of Life Symptom Management

Understanding mRNA Vaccines: Dispelling Myths and Empowering Pharmacists to Counsel Patients (Pharmacy Technician Credit)

Understanding mRNA Vaccines: Dispelling Myths and Empowering Pharmacists to Counsel Patients

Precision Matters: Foundations of Biomarker-Driven Care in Non-Small Cell Lung Cancer

From Testing to Treatment: Empowering Pharmacists to Overcome Barriers and Optimize Biomarker-Driven Care

Navigating the Legal Landscape of Telehealth: Updates and Implications for Pharmacists and Technicians (Pharmacy Technician Credit)

Navigating the Legal Landscape of Telehealth: Updates and Implications for Pharmacists and Technicians

Trending on Drug Topics

Pharmacist Involvement Speeds Prior Authorization for GLP-1s

The 2026 GLP-1 Compounding Crackdown: A Pharmacist’s Guide

Navigating Compounding Peptides and GLP-1s Through Regulations

Understanding the Restructure of US Pharmacy Benefits Amid Reform, Regulatory Action

Finance Strategies for Independent Pharmacies Facing Shrinking Margins